News . Data . Research
Edwards Lifesciences Corp (EW) Q1 2020 earnings call dated Apr. 23, 2020 Corporate Participants: Mark Wilterding -- Vice President, Investor Relations Michael A. Mussallem -- Chairman
Intuitive Surgical Inc (ISRG) Q1 2020 earnings call dated Apr. 16, 2020 Corporate Participants: Calvin Darling -- Senior Director, Finance, Investor Relations Gary S.
Intuitive Surgical Inc. (NASDAQ: ISRG) reported higher earnings and revenues for the first quarter of 2020. The results also topped the Street
Abbott Laboratories (ABT) Q1 2020 earnings call dated Apr. 16, 2020 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing and Acquisitions
Abbott Laboratories (NYSE: ABT) reported its financial results for the quarter ended March 31, 2020 today. The company reported a 16% drop
When Wall Street suffered huge losses after business activity was disrupted across the country due to the COVID-19 outbreak, one industry that
Johnson & Johnson (JNJ) Q1 2020 earnings call dated Apr. 14, 2020. Corporate Participants: Chris DelOrefice -- Vice President, Investor Relations Alex Gorsky -- Chairman, Board
AngioDynamics Inc (ANGO) Q2 2020 earnings call dated Jan. 07, 2020 Corporate Participants: Jim Clemmer -- President, Chief Executive Officer, Director Steve Trowbridge -- Senior Vice
Boston Scientific Corp (NYSE: BSX) Q4 2019 Earnings Conference Call February 05, 2020 Corporate Participants: Susie Lisa -- Vice President of Investor Relations Michael
Abiomed Inc (NASDAQ: ABMD) Q3 2020 Earnings Conference Call February 06, 2020 Corporate Participants: Todd A. Trapp -- Vice President and Chief Financial Officer
Abbott Laboratories (NYSE: ABT) Q4 2019 Earnings Conference Call Jan. 22, 2020 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing and Acquisitions
Medtronic PLC (NYSE: MDT) Q3 2020 Earnings Conference Call Feb. 18, 2020 Corporate Participants: Ryan Weispfenning -- Vice President, Head of Investor Relations Omar Ishrak -- Chairman
Johnson & Johnson (NYSE: JNJ) Q4 2019 Earnings Conference Call Jan. 22, 2020 Corporate Participants: Christopher DelOrefice -- Vice President of Investor Relations Alex Gorsky -- Chairman,
10x Genomics, Inc. (NASDAQ: TXG) Q4 2019 Earnings Conference Call Final Transcript CORPORATE PARTICIPANTS: Carrie Mendivil -- Investor Relations Serge Saxonov -- Chief Executive Officer, Co-founder Justin
Align Technology Inc. (NASDAQ: ALGN) stock plunged to a 3-year low of $161.39 on Monday as the global pandemic overshadowed its growth
Shares of SmileDirectClub Inc. (NASDAQ: SDC) plunged over 52% to $7.17 on Thursday, which is the lowest since the initial public offering
-- Tandem Diabetes (NASDAQ: TNDM) reported earnings of $0.04 per share in the fourth quarter of 2019, vs $0.05 per share loss expected --
-- Aethlon Medical (NASDAQ: AEMD) reported third quarter 2020 net loss attributable to company of $820,000 or $0.28 per share vs. a
-- Boston Scientific (NYSE: BSX) reported earnings of $0.46 per share in the fourth quarter of 2019, vs. $0.44 per share expected. -- Total
-- Stryker (NYSE: SYK) reported fourth quarter 2019 earnings of $2.49 per share, vs. $2.46 per share expected. -- Total sales grew
Johnson & Johnson (NYSE: JNJ) topped earnings estimates for the fourth quarter of 2019 while revenues fell short of expectations. The shares